Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
This triple receptor activation distinguishes it from older medications that target only one or two
Gut-Brain Axis Support It may influence neurochemical pathways, enhancing communication between the gut and central nervous system
Why choose Heally to get CJC-1295
The Department of Veterans Affairs is launching a nationwide clinical trial to determine whether semaglutide, marketed as Ozempic for Type 2 diabetes and Wegovy for chronic weight management, can help treat alcohol use disorder in veterans, a condition VA says has been diagnosed in more than 400,000 veterans nationwide
Retatrutide (5mg-10mg), Triple Incretin Receptor Agonist Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Introduction Engineered Engagement of GLP-1, GIP, and Glucagon Receptors Retatrutide is a synthetic 39-residue peptide engineered as a balanced agonist of three distinct class B G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
doi:10.1056/NEJMoa2307563
